Skip to content
  • Русский
  • Українська
smart-pharma.group
smart-pharma.group
pharmaceutical consulting services
  • Home
  • Services
  • About Us
  • Pharmacovigilance
    • Report AE
  • Blog
  • Contact Us

Tag: Roszdravnadzor

Suspension of use of medicines due to non-compliance with requirements of pharmacovigilance legislation

21/01/2020 admi nistrato

The Federal Service for Supervision in the Sphere of Healthcare (Roszdravnadzor) informs about the decision of the Ministry of Health…

Continue Reading →

Filed under: medicinal products, pharmacovigilance, Roszdravnadzor, safety of the medicinal product, serious undesirable reactions

Recent Posts

  • The Russian side opposed to postpone Implementation period of the EAEU Rules of marketing authorisation 03/12/2020
  • MedSafety app launch in the Kyrgyz Republic 25/11/2020
  • Important amendments to the EAEU legislative acts 20/10/2020

Recent Comments

    Archives

    • December 2020
    • November 2020
    • October 2020
    • September 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • August 2019

    Contact Us

    info@smart-pharma.group

    Head office EU:
    23 Upes St., Vilnus,
    LT-08128, Lithuania

    +37 052 060 0 94


    CIS office:
    26 Peremohy Ave,
    Kyiv, 04116, Ukraine

    +38 044 390 31 90

    Follow Us

    EAEU office:
    7 Aprelia St., 2/10, 48,
    Bishkek, 72007, Kyrgystan

    +99 655 007 7073

    • About Us
    • Services
    • Pharmacovigilance
    Copyright © 2024 smart-pharma.group